122 related articles for article (PubMed ID: 38296539)
1. Biofilm eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-sulfamethoxazole.
Del Río-Chacón JM; Rojas-Larios F; Bocanegra-Ibarias P; Salas-Treviño D; Espinoza-Gómez F; Camacho-Ortiz A; Flores-Treviño S
Jpn J Infect Dis; 2024 Jan; ():. PubMed ID: 38296539
[TBL] [Abstract][Full Text] [Related]
2. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
Flores-Treviño S; Gutiérrez-Ferman JL; Morfín-Otero R; Rodríguez-Noriega E; Estrada-Rivadeneyra D; Rivas-Morales C; Llaca-Díaz JM; Camacho-Ortíz A; Mendoza-Olazarán S; Garza-González E
J Med Microbiol; 2014 Nov; 63(Pt 11):1524-1530. PubMed ID: 25165124
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates.
Bostanghadiri N; Ardebili A; Ghalavand Z; Teymouri S; Mirzarazi M; Goudarzi M; Ghasemi E; Hashemi A
BMC Res Notes; 2021 Apr; 14(1):151. PubMed ID: 33879237
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Phenotypic and Genotypic Diversity of
Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A
Front Microbiol; 2019; 10():1191. PubMed ID: 31191502
[No Abstract] [Full Text] [Related]
5. Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole on
Montoya-Hinojosa EI; Salazar-Sesatty HA; Alvizo-Baez CA; Terrazas-Armendariz LD; Luna-Cruz IE; Alcocer-González JM; Villarreal-Treviño L; Flores-Treviño S
Expert Rev Anti Infect Ther; 2023 Feb; 21(2):213-223. PubMed ID: 36625029
[TBL] [Abstract][Full Text] [Related]
6.
Su BA; Chen CC; Chen HJ; Lai HY; Tsai CH; Lai CC; Tang HJ; Chao CM
Front Microbiol; 2023; 14():1186669. PubMed ID: 37408643
[TBL] [Abstract][Full Text] [Related]
7. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
8. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
10. The effects of emerging environmental contaminants on Stenotrophomonas maltophilia isolated from drinking water in planktonic and sessile states.
Gomes IB; Simões LC; Simões M
Sci Total Environ; 2018 Dec; 643():1348-1356. PubMed ID: 30189551
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.
Sun E; Liang G; Wang L; Wei W; Lei M; Song S; Han R; Wang Y; Qi W
Braz J Infect Dis; 2016; 20(4):365-73. PubMed ID: 27183359
[TBL] [Abstract][Full Text] [Related]
12. The Relationship between the Biofilm Genes and Antibiotic Resistance in
Sameni F; Hajikhani B; Hashemi A; Owlia P; Niakan M; Dadashi M
Int J Microbiol; 2023; 2023():8873948. PubMed ID: 37692920
[TBL] [Abstract][Full Text] [Related]
13. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
14. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
15. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
16. Relationship between antibiotic resistance with class 1 integron and SmeDEF efflux pump encoding genes in clinical isolates of Stenotrophomonas maltophilia.
Bafandeh Zamanpour S; Yousefi Mashouf R; Salimizand H; Nazari M; Alikhani MY; Farajnia S
J Appl Genet; 2023 Sep; 64(3):591-597. PubMed ID: 37574492
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
18. Molecular Epidemiology of
Divakan H; Alikhani MY; Shokoohizadeh L
Oman Med J; 2023 May; 38(3):e505. PubMed ID: 37346891
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
Nys C; Cherabuddi K; Venugopalan V; Klinker KP
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427300
[No Abstract] [Full Text] [Related]
20. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
Lee YL; Liu CE; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]